During the last session, biote Corp (NASDAQ:BTMD)’s traded shares were 0.31 million, with the beta value of the company hitting 1.01. At the end of the trading day, the stock’s price was $5.98, reflecting an intraday loss of -2.61% or -$0.16. The 52-week high for the BTMD share is $8.44, that puts it down -41.14 from that peak though still a striking 38.96% gain since the share price plummeted to a 52-week low of $3.65. The company’s market capitalization is $324.94M, and the average intraday trading volume over the past 10 days was 0.26 million shares, and the average trade volume was 162.48K shares over the past three months.
biote Corp (BTMD) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. BTMD has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.17.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
biote Corp (NASDAQ:BTMD) trade information
biote Corp (BTMD) registered a -2.61% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -2.61% in intraday trading to $5.98, hitting a weekly high. The stock’s 5-day price performance is 10.95%, and it has moved by 19.12% in 30 days. Based on these gigs, the overall price performance for the year is 15.89%. The short interest in biote Corp (NASDAQ:BTMD) is 0.81 million shares and it means that shorts have 7.82 day(s) to cover.
The consensus price target of analysts on Wall Street is $8.62, which implies an increase of 30.63% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $8.24 and $9 respectively. As a result, BTMD is trading at a discount of -50.5% off the target high and -37.79% off the low.
biote Corp (BTMD) estimates and forecasts
Statistics show that biote Corp has underperformed its competitors in share price, compared to the industry in which it operates. biote Corp (BTMD) shares have gone down -5.83% during the last six months, with a year-to-date growth rate less than the industry average at 7.69% against 11.50. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to grow 68.28% this quarter and then drop -41.03% in the quarter after that. In the rating firms’ projections, revenue will increase 7.13% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 51.29M as predicted by 5 analyst(s). Meanwhile, a consensus of 3 analyst(s) estimates revenue growth to 53.62M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 45.7M and 46.8M respectively. In this case, analysts expect current quarter sales to grow by 12.23% and then jump by 14.56% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -19.96%. While earnings are projected to return 84.62% in 2024.
BTMD Dividends
biote Corp is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
biote Corp (NASDAQ:BTMD)’s Major holders
biote Corp insiders own 27.60% of total outstanding shares while institutional holders control 64.70%, with the float percentage being 89.37%. 325 CAPITAL LLC is the largest shareholder of the company, while 123.0 institutions own stock in it. As of 2024-06-30, the company held over 3.77 million shares (or 10.8797% of all shares), a total value of $28.14 million in shares.
The next largest institutional holding, with 2.44 million shares, is of BANDERA PARTNERS LLC’s that is approximately 7.0351% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $18.19 million.
Also, the Mutual Funds coming in first place with the largest holdings of biote Corp (BTMD) shares are Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF . Data provided on Jun 30, 2024 indicates that Vanguard Total Stock Market Index Fund owns about 856.6 shares. This amounts to just over 2.70 percent of the company’s overall shares, with a $5.12 million market value. The same data shows that the other fund manager holds slightly less at 680.88, or about 2.14% of the stock, which is worth about $4.07 million.
